Key Takeaways: Read also: Gotrade Daily: AWS Roars Back, Microsoft's Record Day Pfizer keeps expanding its GLP-1 portfolio in China through its second licensing deal in just a few months Ecnoglutide is a once-weekly injection already approved in China, with a weight management application currently under review Competition in the GLP-1 space is heating up fast, with heavyweights like Novo Nordisk and Eli Lilly already leading the pack Ecnoglutide belongs to a class of drugs known as GLP-1 receptor agonists, the same category as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro
Saxenda is now primarily used as a weight management aid instead of as a diabetes drug
Relafen (nabumetone): Relafen is approved to treat pain and inflammation caused by rheumatoid arthritis and osteoarthritis
NIDDK Prescription Medications to Treat Overweight & Obesity U.S
With proper guidance and simple lifestyle tweaks, most can continue treatment successfully and stay on track toward their health goals
Es como cuando Cristbal Coln lleg a Amrica, y pens en mapearla para orientarse, explica Al-Aly